Haute Capital Partners

Haute Capital Partners is a Swiss private equity investment firm that operates as a listed holding company on the BX Swiss Exchange. The firm's core mission is to provide both private and institutional investors with direct access to a carefully curated portfolio of high-growth, non-listed Swiss companies. By structuring itself as a publicly traded entity, Haute Capital Partners aims to democratize access to private markets, which have historically been exclusive to institutional investors and established family offices due to high minimum commitments and long lock-up periods. The firm's shares are fully denominated in Swiss francs, offering stability and transparency to its investors.

Founded in 2017 by Thibault Leroy Bürki, Haute Capital Partners was established with the vision of bridging the gap between Switzerland's innovative private companies and a broader investor base. The firm identifies companies with significant intrinsic potential through proprietary deal flow, rigorous due diligence, and deep sector expertise. Beyond capital investment, Haute Capital Partners actively collaborates with management teams, providing strategic accompaniment to accelerate growth, strengthen governance, and facilitate access to new markets and relationships. The firm emphasizes patient capital, focusing on long-term value creation rather than short-term optimization.

Haute Capital Partners invests across a diverse range of sectors critical to Switzerland's innovation landscape. Its portfolio includes companies such as BioCopy, an AI-powered antibody engineering platform; Care, an AI-driven preventive health and longevity platform; Neolido Technology, specializing in fire-retardant composite materials; Aisot Technologies, an AI-powered quantitative investment intelligence firm; PB&B, focused on regenerative injectable solutions for medical aesthetics; and Splint Invest, a fractional alternative asset platform. The firm's investment strategy also extends to opportunities in blockchain, cryptocurrencies, and decentralized finance, alongside traditional private equity and real estate.

The leadership team at Haute Capital Partners brings a wealth of experience to its investment and operational strategies. Key members include Thibault Leroy Bürki, CEO & Chairman of the Board of Directors; Dieter Bratschi, Member of the Board of Directors; Dylan Figueiredo, Chief Investment Officer; Ursula Wermeille, Chief Operating Officer; Rodrigo Bento Geraldes, Chief Investor Relations Officer; and Reto Arpagaus, Advisory Board. This team is dedicated to managing the diversified portfolio and ensuring transparent reporting as a listed company, adhering to regulatory disclosure obligations on the BX Swiss Exchange.